These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 9306774)
21. Medical devices; preemption of state product liability claims--FDA. Proposed rule. Fed Regist; 1997 Dec; 62(239):65384-8. PubMed ID: 10176832 [TBL] [Abstract][Full Text] [Related]
22. The government's role in advancing regenerative medicine and tissue engineering - science, safety, and ethics. Smith DS Periodontol 2000; 2006; 41():16-29. PubMed ID: 16686924 [No Abstract] [Full Text] [Related]
23. Preemption and medical devices: a response to Adler and Mann. Hermann M; Ritts GJ Food Drug Law J; 1996; 51(1):1-19. PubMed ID: 11794345 [TBL] [Abstract][Full Text] [Related]
24. Medical devices; device tracking. Final rule. Food and Drug Administration, HHS Fed Regist; 2002 Feb; 67(27):5943-52. PubMed ID: 11838471 [TBL] [Abstract][Full Text] [Related]
25. Ensuring adequate rewards for risk. Ribicoff A MPS; 1980 Nov; 11(11):88-92. PubMed ID: 10249173 [No Abstract] [Full Text] [Related]
26. The need for FDA regulation of tobacco products. Kennedy EM Yale J Health Policy Law Ethics; 2002; 3(1):101-8. PubMed ID: 12825428 [No Abstract] [Full Text] [Related]
27. Medical devices and the law: the hospital's responsibilities. Health Technol; 1989; 3(3):3-27. PubMed ID: 10296777 [No Abstract] [Full Text] [Related]
28. Medical Device Manufacturing and Medical Device Reports (MDR). Arellano V Insight; 2009; 34(3):24-5. PubMed ID: 19708431 [No Abstract] [Full Text] [Related]
29. The trouble with recalls. Consum Rep; 2004 Aug; 69(8):12-7. PubMed ID: 15243992 [No Abstract] [Full Text] [Related]
30. Device tracking: user facility responsibilities. Shepherd N J Clin Eng; 1993; 18(5):441-52. PubMed ID: 10129809 [TBL] [Abstract][Full Text] [Related]
31. Medical device reporting: another final rule, Part I. Donawa M Med Device Technol; 2000 Mar; 11(2):40-2. PubMed ID: 10915493 [TBL] [Abstract][Full Text] [Related]
32. Postmarket surveillance. Final rule. Food and Drug Administration, HHS Fed Regist; 2002 Jun; 67(109):38878-92. PubMed ID: 12053947 [TBL] [Abstract][Full Text] [Related]
33. FDA regulatory compliance reconsidered. Tobias C Cornell Law Rev; 2008 Jul; 93(5):1003-38. PubMed ID: 18618969 [No Abstract] [Full Text] [Related]
34. Medical devices; procedures for premarket notification, premarket approval, classification, performance standards establishment, banning devices, and availability of regulatory hearings--FDA. Final rule. Fed Regist; 1992 Dec; 57(238):58400-6. PubMed ID: 10123143 [TBL] [Abstract][Full Text] [Related]
35. The FDA's reaction to corporate compliance audits. Shroff AP Food Drug Law J; 1996; 51(2):221-3. PubMed ID: 11820199 [No Abstract] [Full Text] [Related]
36. CFSAN's program priorities: from food safety to food security. Levitt JA Food Drug Law J; 2003; 58(1):19-24. PubMed ID: 12739581 [No Abstract] [Full Text] [Related]
37. An overview from the Director of the Center for Food Safety and Applied Nutrition. Levitt JA Food Drug Law J; 1999; 54(1):43-48. PubMed ID: 11758559 [No Abstract] [Full Text] [Related]
38. Simplifying compliance activities. Jt Comm Perspect; 2001 Mar; 21(3):6-7. PubMed ID: 11270206 [No Abstract] [Full Text] [Related]
39. To eat or not to eat? Food safety in the United States. Galson SK J Am Diet Assoc; 2009 Jul; 109(7):1142. PubMed ID: 19559125 [No Abstract] [Full Text] [Related]